Intuitive Surgical dips on slower procedure growth forecast
Surgical robot maker Intuitive Surgical's ISRG.O shares fall 3.1% to $590.01 premarket, fourth biggest decliner among S&P 500 components before the bell
ISRG expects the number of procedures using its da Vinci robots to grow between 13-16% in 2025, versus 17% growth in 2024, it said late on Thursday
"While the procedure guidance ... is a step down from recent years, historically ISRG has started conservatively and beaten them," says Evercore ISI analyst Vijay Kumar in a note titled "deciphering the da Vinci code is an art"
ISRG has beaten EPS estimates for eight straight quarters, according to LSEG data
The company also reported an adjusted profit of $2.21 per share in Q4, beating analysts' estimates of $1.79 per share
ISRG shares have been trading at record highs since it pre-reported Q4 revenue on Jan. 15, touching all-time highs in the past 6 straight sessions; stock up ~64% in the past 12 months
Related Articles
Tech Giants' AI CapEx on Corporate Debt: A Riskier Race?
TradingKey - The narrative surrounding the AI bubble is growing more complex as tech giants like Meta and Google aggressively tap corporate bond markets to finance surging capital expenditures and AI infrastructure. Investors are increasingly concerned that massive corporate debt and novel
Oklo Stock Price Drops 24% After Oklo Earnings Released: What's Oklo Stock Price Target? Is Oklo Stock a Buy Now?
TradingKey - Oklo, a California-based advanced nuclear technology company backed by OpenAI CEO Sam Altman, currently remains unprofitable. Founded in 2013, the firm specializes in designing and building small modular reactors (SMRs), aiming to provide clean, reliable energy solutions. Furthermore, A
The Jobs Puzzle During the Shutdown: From Weak ADP to a Rebounding September NFP and an October Surprise Dip
TradingKey - The longest US government shutdown on record is nearing its end, potentially providing the data-deprived Federal Reserve with the September nonfarm payrolls report as early as this week once federal operations resume. However, the October nonfarm data may be permanently lost. During the
CoreWeave Q3 2025 Earnings Analysis: Short-Term Hypergrowth vs. Long-Term Leverage Risks—Trading Opportunity or Trap?
CoreWeave Q3 2025: Revenue +134% to $1.36B, loss narrows to $110M, but guidance cut, op margin 4%, $14B debt. AI infra boom via NVIDIA/OpenAI deals, 50%+ GPU util, $55.6B backlog. Short-term trade, long-term leverage trap.
Strategy (MSTR): Why This Bitcoin Proxy Is Decoupling From BTC — And Is It Still a Buy?
TradingKey - Strategy stock is in a sustained decline and remains entrenched in a downward channel, as Bitcoin continues to fall and briefly dipped below $100,000 on November 4, leading to a sharp decline in Bitcoin-related stocks. We believe Strategy’s slump has not yet abated.
